One key mechanism involves activation of the NF-κB pathway and the NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome, both of which are strongly implicated in Alzheimer’s disease (AD) and related dementias [77,78]. Here, NFKB1 is linked to Alzheimer disease.